Search

Clifton, M. C., D. M. Dranow, A. Leed, B. Fulroth, J. W. Fairman, J. Abendroth, K. A. Atkins, et al. 2015. “A Maltose-Binding Protein Fusion Construct Yields a Robust Crystallography Platform for MCL1”. PLoS One 10: e0125010.

Corsello, S. M., R. T. Nagari, R. D. Spangler, J. Rossen, M. Kocak, J. G. Bryan, R. Humeidi, et al. 2020. “Discovering the Anti-Cancer Potential of Non-Oncology Drugs by Systematic Viability Profiling”. Nat Cancer 1: 235-48.

Cowley, G. S., B. A. Weir, F. Vazquez, P. Tamayo, J. A. Scott, S. Rusin, A. East-Seletsky, et al. 2014. “Parallel Genome-Scale Loss of Function Screens in 216 Cancer Cell Lines for the Identification of Context-Specific Genetic Dependencies”. Sci Data 1: 140035.

Dempster, J. M., C. Pacini, S. Pantel, F. M. Behan, T. Green, J. Krill-Burger, C. M. Beaver, et al. 2019. “Agreement Between Two Large Pan-Cancer CRISPR-Cas9 Gene Dependency Data Sets”. Nat Commun 10: 5817.

JC, Caicedo, Goodman A, Karhohs KW, Cimini BA, Ackerman J, Haghighi M, Heng C, et al. 2019. “Nucleus Segmentation across Imaging Experiments: The 2018 Data Science Bowl”. Nature Methods 16 (12): 1247-53.

Caicedo, Juan, Shantanu Singh, and Anne Carpenter. 2016. “Applications in Image-Based Profiling of Perturbations”. Current Opinion in Biotechnology 39: 134-42.

Tekin, Halil, Sean Simmons, Beryl Cummings, Linyi Gao, Xian Adiconis, Cynthia Hession, Ayan Ghoshal, et al. 2018. “Effects of 3D Culturing Conditions on the Transcriptomic Profile of Stem-Cell-Derived Neurons”. Nature Biomedical Engineering 2 (7): 540–554.

Adalsteinsson, V. A., G. Ha, S. S. Freeman, A. D. Choudhury, D. G. Stover, H. A. Parsons, G. Gydush, et al. 2017. “Scalable Whole-Exome Sequencing of Cell-Free DNA Reveals High Concordance With Metastatic Tumors”. Nat Commun 8: 1324.

Antipova, A. A., P. Tamayo, and T. R. Golub. 2002. “A Strategy for Oligonucleotide Microarray Probe Reduction”. Genome Biol 3: RESEARCH0073.

Armstrong, S. A., A. L. Kung, M. E. Mabon, L. B. Silverman, R. W. Stam, M. L. Den Boer, R. Pieters, et al. 2003. “Inhibition of FLT3 in MLL. Validation of a Therapeutic Target Identified by Gene Expression Based Classification”. Cancer Cell 3: 173-83.